Author:
Palma Marzia,Hansson Lotta,Choudhury Aniruddha,Näsman-Glaser Barbro,Eriksson Ingrid,Adamson Lars,Rossmann Eva,Widén Karin,Horváth Rudolf,Kokhaei Parviz,Vertuani Simona,Mellstedt Håkan,Österborg Anders
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference41 articles.
1. Hallek M, Fischer K, Fingerle-Rowson G et al (2010) Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 376:1164–1174. doi: S0140-6736(10)61381-5
2. Wierda WG, Kipps TJ, Dürig J et al. (2009) Ofatumumab combined with fludarabine and cyclophosphamide (O-FC) Shows high activity in patients with previously untreated chronic lymphocytic leukemia (CLL): Results from a randomized, multicenter, international, two-dose, parallel group, phase II trial. Blood (ASH annual meeting abstracts) 114 (abs. 207)
3. Badoux X, Keating MJ, O′Brien SM et al. (2009) Long term results of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) for patients with relapsed and refractory chronic lymphocytic leukemia. Haematologica 94 (suppl. 3):abs. 10.32
4. Fiammenghi L, Ancarani V, Rosales T et al (2010) FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy. J Transl Med 8:52. doi: 1479-5876-8-52
5. Kokhaei P, Choudhury A, Mahdian R et al (2004) Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL. Leukemia 18:1810–1815
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献